<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03070028</url>
  </required_header>
  <id_info>
    <org_study_id>PS001</org_study_id>
    <nct_id>NCT03070028</nct_id>
  </id_info>
  <brief_title>Minimally Invasive Treatment Methods for Pilonidal Disease</brief_title>
  <official_title>Randomized Prospective Comparison of Crystallized Phenol and Platelet Rich Plasma Applications in Treatment of Pilonidal Sinus Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Uşak University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Uşak University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patients with pilonidal sinus disease will be randomised to two groups (crystallised phenol
      and platelet rich plasma). Sinus healing time, patient satisfaction, complications and
      recurrence rates will be compared.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients with pilonidal sinus disease will be treated by either crystallised phenol or
      platelet rich plasma application. Treatment results, healing time, postprocedural
      complications, patient satisfaction and recurrences will be compared.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">June 1, 2018</start_date>
  <completion_date type="Anticipated">December 1, 2019</completion_date>
  <primary_completion_date type="Anticipated">December 1, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>healing time</measure>
    <time_frame>first 1 year of the study</time_frame>
    <description>Time to complete closure of the sinus cavity.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Pilonidal Sinus</condition>
  <arm_group>
    <arm_group_label>Phenol</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>crystallised phenol application</description>
  </arm_group>
  <arm_group>
    <arm_group_label>platelet rich plasma</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>PRP application</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>crystallised phenol</intervention_name>
    <description>crystallised phenol will be applied to sinus cavity</description>
    <arm_group_label>Phenol</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Platelet rich plasma</intervention_name>
    <description>platelet rich plasma will be applied to sinus cavity</description>
    <arm_group_label>platelet rich plasma</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Having pilonidal sinus disease

          -  accepting to be involved in the study

        Exclusion Criteria:

          -  below the age of 18

          -  having connective tissue disorders

          -  diabetes mellitus

          -  severe anemia
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Barış Sevinç, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Uşak University Medical School</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Barış Sevinç, M.D.</last_name>
    <phone>5054880511</phone>
    <email>baris.sevinc@usak.edu.tr</email>
  </overall_contact>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 28, 2017</study_first_submitted>
  <study_first_submitted_qc>February 28, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">March 3, 2017</study_first_posted>
  <last_update_submitted>February 6, 2018</last_update_submitted>
  <last_update_submitted_qc>February 6, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 7, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Uşak University</investigator_affiliation>
    <investigator_full_name>Barış Sevinç</investigator_full_name>
    <investigator_title>assistant proffessor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pilonidal Sinus</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Phenol</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

